A simple clip could increase quality of life for thousands of patients with a common heart problem

December 15, 2011

The interventional cardiology team at the Montreal Heart Institute (MHI) recently conducted the first clinical procedure in Canada using the MitraClip system, which is designed to treat patients suffering from mitral valve failure, a very common heart defect that affects an estimated 1 out 5 people to various extents starting at the age of 55. The MHI has implemented a treatment program for this condition and so far is the centre that has performed the most procedures in Canada with the MitraClip system.

This innovative and minimally is an alternative to heart surgery. Until now, mitral valve failure has been treated with medication or open-heart surgery depending on the degree of severity. The MitraClip system was designed by Abbott Vascular for inoperable or very high-risk and can provide lasting treatment for acute mitral regurgitation. The risk of complications is low compared to , and patients are discharged from the hospital within 48 hours of the procedure.

The first procedure was performed by a multidisciplinary team made up of cardiologists Anita Asgar, Anique Ducharme, Raoul Bonan and Arsène Basmadjian along with anesthesiologists Jennifer Cogan and Baqir Qizilbash. "All initial cases went well, and we believe that the long-term outcomes for this procedure will be favourable," stated Dr. Anita Asgar, interventional cardiologist and Assistant Professor in the Faculty of Medicine at Université de Montréal. "Since it allows patients to regain autonomy and quality of life, we believe that this treatment will reduce the number of hospital admissions and visits to emergency due to symptom reoccurrence."

The procedure consists of using a catheter to guide the MitraClip, a simple clip device, through the femoral vein to the left atrium of the heart and then pushing it into the ventricle. The clip is then positioned so that it holds the anterior and posterior flaps of the together. This creates a double orifice opening that allows blood to flow on both sides of the clip, which mechanically restricts regurgitation.

Explore further: MitraClip Therapy demonstrates benefits for heart failure patients

Related Stories

Recommended for you

No new heart muscle cells in mice after the newborn period

November 5, 2015

A new study from Sweden's Karolinska Institutet shows that new heart muscle cells in mice are mainly formed directly after birth. After the neonatal period the number of heart muscle cells does not change, and A new study ...

Nanotechnology could spur new heart treatment

October 29, 2015

A new nanoparticle developed by University of Michigan researchers could be the key to a targeted therapy for cardiac arrhythmia, a condition that causes the heart to beat erratically and can lead to heart attack and stroke.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.